688626 翔宇医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.2133.8054.98611.3056.497
总资产报酬率 ROA (%)0.7632.5233.7309.1595.514
投入资产回报率 ROIC (%)0.8772.9144.31210.4686.115

边际利润分析
销售毛利率 (%)68.20166.62967.41968.62166.274
营业利润率 (%)13.8349.99114.59432.84527.729
息税前利润/营业总收入 (%)12.9457.62811.23328.76121.769
净利润/营业总收入 (%)12.8969.89713.83330.65425.238

收益指标分析
经营活动净收益/利润总额(%)92.96555.26181.15288.16556.026
价值变动净收益/利润总额(%)-4.9778.6521.3063.80810.265
营业外收支净额/利润总额(%)-0.166-3.059-1.192-0.245-1.858

偿债能力分析
流动比率 (X)1.6771.5631.5543.2094.742
速动比率 (X)1.3371.2431.2302.5614.109
资产负债率 (%)37.23736.33729.82018.69918.083
带息债务/全部投入资本 (%)23.24721.35614.1091.6584.537
股东权益/带息债务 (%)307.238342.425570.0815,627.7522,023.870
股东权益/负债合计 (%)167.730174.292233.500431.387450.141
利息保障倍数 (X)-14.948-3.691-3.522-7.185-3.992

营运能力分析
应收账款周转天数 (天)34.02729.25528.73420.64026.801
存货周转天数 (天)460.142381.073356.335357.501417.574